Brand name: Obizur TM
Active ingredients: susoctocog alfa
What it is used for
for the treatment of bleeding episodes in adults with acquired haemophilia A.,Safety and efficacy of OBIZUR have not been established in patients with baseline anti- porcine factor VIII inhibitor titre greater than 20 BU.,OBIZUR is not indicated for the treatment of congenital haemophilia A or von Willebrand disease.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection
Clear and colourless solution, practically free from visible particles
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Part 2: Injection
No information available
The way to take this medicine is: Intravenous. This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Refrigerate
- Shelf lifetime is 3 Years.
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Pregnant or planning a pregnancy?
For the active ingredient susoctocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems